1. People's Republic of China Stocks

  2. •

    Consumer Cyclical

  3. •

    Department Stores
Xi'an International Medical Investment Company Limited

Xi'an International Medical Investment Company Limited

000516.SZ
Xi'an International Medical Investment Company LimitedCN flagShenzhen Stock Exchange
3.99
CNY
-0.01
- -
8.93BMarket Cap
Xi'an International Medical Investment Company Limited
000516.SZ
(Shenzhen Stock Exchange)

Recent

price

3.99

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.39
1.91
1.96
2
2.17
5.18
1.95
2.09
1.04
0.52
0.71
1.31
1.2
2.01
2.08
1.82
1.96
Revenue per Share
0.08
0.07
0.06
0.07
0.2
0.32
0.1
0.1
1.11
-0.21
0.02
-0.37
-0.52
-0.16
-0.11
-0.14
-0.11
Basic EPS, GAAP
0.1
0.2
0.21
0.07
0.11
-0.11
0.11
-0.27
-1.26
-1.9
-0.57
-0.54
-0.32
0.14
0.2
0.45
-0.17
Free Cash Flow per Basic Share
0.03
0.03
0.06
0.06
0.05
0.07
0.04
0.05
0.01
0.14
0.09
0.1
0.11
0.09
0.08
0.07
0.07
Dividend per Share
0.48
0.56
0.6
0.63
0.79
2.28
1.51
1.63
2.61
2.37
2.03
1.84
1.29
1.1
0.99
0.87
0.93
Book Value per Share
0.53
0.5
0.56
0.55
0.73
3.73
1.48
1.59
2.68
2.28
1.92
2.09
1.54
1.33
1.2
1.04
1.11
Tangible Book Value per Share
1,812
1,767
1,735
1,787
1,787
753
2,016
1,945
1,968
1,923
2,268
2,222
2,263
2,302
2,310
2,236
2,258
Basic Weighted Avg Shares
2,526
3,378
3,403
3,566
3,883
3,900
3,931
4,060
2,039
991
1,607
2,921
2,711
4,618
4,815
4,075
4,429
Sales/Revenue/Turnover
6.94
6.58
6.24
6.92
9.11
7.81
7.72
7.1
5.21
-28.33
-36.86
-22.58
-32.28
-6.51
-3.87
-7.37
-5.81
Operating Margin (%)
62
81
117
116
107
106
116
120
82
121
376
569
620
770
731
688
- -
Depreciation Expense
152
127
111
122
350
241
202
195
2,184
-404
45
-822
-1,177
-368
-254
-313
-245
Net Income, GAAP
26.16
30.9
30.61
24.25
20
23.77
24.4
26.56
26.43
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
6.03
3.77
3.26
3.41
9.02
6.18
5.13
4.79
107.11
-40.76
2.82
-28.15
-43.4
-7.98
-5.28
-7.68
-5.54
Profit Margin (%)
-103
-955
-957
-886
-416
825
866
-50
1,400
-245
-803
-1,165
-1,817
-2,203
-2,536
-3,321
-3,025
Working Capital
308
157
85
70
124
175
100
130
571
3,155
3,906
4,452
3,474
3,376
2,997
2,169
2,571
LT Debt
1,069
1,118
1,193
1,283
1,597
3,328
3,499
3,717
5,797
4,996
5,033
5,331
4,251
3,816
3,472
3,007
3,210
Total Equity
7.2
7.85
7.22
9.08
12.17
6.69
5.13
4.56
1.39
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
11.95
8.99
8.55
9.23
18.68
11.07
6.91
5.54
42.41
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
20.73
13.74
10.95
11.2
27.56
15.4
8.47
6.26
52.59
-8.32
0.99
-18.88
-33.56
-13.51
-10.56
-14.82
-11.02
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1,640
1,712
1,880
LT Borrowings
2,997
2,887
2,571
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,260
2,260
2,239
Market Capitalization
11,938
12,306
11,764

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,615
1,357
1,186
Cash, Cash Equivalents & STI
680
487
413
Accounts Receivable, Net
739
691
594
Inventories
81
63
61
Total Current Liabilities
4,151
4,075
4,211
Payables & Accruals
- -
- -
- -
ST Debt
1,640
1,712
1,880
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.73%
-9.4%
-13.38%
Free Cash Flow
-36.25%
-5.92%
119.78%
Net Income, GAAP
-117.27%
-389.18%
23.2%
Sales/Revenue/Turnover
9.89%
26.76%
-15.39%
Total Cash Common Dividend
102.09%
-4.35%
-18.78%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,173
1,248
1,186
1,209
4,815
2025
997
1,037
1,079
- -
4,075
2026
969
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
- -
- -
- -
-0.11
2025
-0.05
- -
- -
- -
-0.14
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
- -
- -
- -
0.08
2025
0.02
- -
- -
- -
0.07
2026
0.01
- -
- -
- -
- -
Similar Companies
Ccoop Group Co., Ltd (000564.SZ)
Rusta AB (publ) (RUSTA.ST)
Lianhua Supermarket Holdings Co., Ltd. (LHUAF)
Yinchuan Xinhua Commercial (Group) Co., Ltd. (600785.SS)
Tokyu Corporation (TOKUF)
LUDWIG BECK am Rathauseck - Textilhaus Feldmeier AG (ECK.DE)
Business
Xi'an International Medical Investment Company Limited Xi'an International Medical Investment Company Limited (000516.SZ) is a China-based company primarily engaged in healthcare services and the transformation and application of modern medical technology. The company operates hospitals and medical centers; provides insurance broking services; engages in tourism-related activities; and undertakes pharmaceutical production. It focuses on large-scale health care operations, including high-end medical platforms, international medical tourism, and advanced treatments such as proton therapy systems, with core systems like hospital information systems (HIS) and electronic medical records (EMR) integrated with locally deployed AI models. Founded in 1986 and headquartered in Xi'an, China, the company, formerly known as Xi'an Kaiyuan Investment Group Co., Ltd., changed its name in January 2015 to reflect its medical investment focus; it listed on the Shenzhen Stock Exchange in 1993 as the region's first listed entity and is included in indices such as the Shenzhen-Hong Kong Stock Connect Composite Index, MSCI China A Index, and S&P Dow Jones China Indices. In recent developments, the company completed local deployment of Medical AI models in early 2025, ensuring data privacy and connectivity with business systems; its proton therapy center project advanced to precision installation and debugging, targeting operational launch by year-end 2025. It executed share repurchases totaling over 13.8 million shares by April 2025 at prices between 4.61 and 5.618 yuan per share; reported 2024 revenue of 4.815 billion yuan, up 4.28% year-over-year, despite net losses; and earned honors including "2024 Benchmark Hospital," "Top 100 Cross-Strait Social Hospitals," and "Western China Social Medical Benchmark Hospital." Ongoing technical collaboration with Alibaba Cloud supports proprietary upgrades and resource expansion.